Načítá se...
Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
Melanoma today is considered as a spectrum of melanocytic malignancies characterised by clinical and molecular features, including targetable mutations in several kinases such as BRAF or c-KIT. The successful development of therapies targeting these mutations has resulted in new specific treatment o...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4041182/ https://ncbi.nlm.nih.gov/pubmed/26217117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejcsup.2013.07.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|